Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dafydd R Owen

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
ACS Chemical Neuroscience|August 4, 2012
Recent advances in the medicinal chemistry of the metabotropic glutamate receptor 1 (mGlu₁)Dafydd R Owen
Drug Discovery Today. Technologies|July 17, 2014
Epigenetic drugs that do not target enzyme activityDafydd R Owen, John D Trzupek
Nature Reviews. Chemistry|July 23, 2025
Protein-ligand data at scale to support machine learningAled M Edwards, Dafydd R Owen,
Current Opinion in Drug Discovery & Development|July 5, 2008
TAFIa inhibitors in the treatment of thrombosisMark E Bunnage, Dafydd R Owen
Scientific Reports|October 6, 2015
Lysine Methyltransferase SETD7 (SET7/9) Regulates ROS Signaling through mitochondria and NFE2L2/ARE pathwayShuying He, Dafydd R Owen, Scott A Jelinsky, et al.
ACS Chemical Biology|March 22, 2021
Structure and Inhibitor Binding Characterization of Oncogenic MLLT1 MutantsXiaomin Ni, Allyn T Londregan, Dafydd R Owen, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2009
Oxygenated analogues of UK-396082 as inhibitors of activated thrombin activatable fibrinolysis inhibitorDafydd R Owen, David J Bull, Mark E Bunnage, et al.
RSC Medicinal Chemistry|January 13, 2022
Investigating 3,3-diaryloxetanes as potential bioisosteres through matched molecular pair analysisMaryne A J Dubois, Rosemary A Croft, Yujie Ding, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2009
Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysisThomas Ryckmans, Martin P Edwards, Val A Horne, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2011
Optimisation of a novel series of selective CNS penetrant CB(2) agonistsChristine Watson, Dafydd R Owen, Denise Harding, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
ACS Chemical Neuroscience|August 4, 2012
Recent advances in the medicinal chemistry of the metabotropic glutamate receptor 1 (mGlu₁)Dafydd R Owen
Drug Discovery Today. Technologies|July 17, 2014
Epigenetic drugs that do not target enzyme activityDafydd R Owen, John D Trzupek
Nature Reviews. Chemistry|July 23, 2025
Protein-ligand data at scale to support machine learningAled M Edwards, Dafydd R Owen,
Current Opinion in Drug Discovery & Development|July 5, 2008
TAFIa inhibitors in the treatment of thrombosisMark E Bunnage, Dafydd R Owen
Scientific Reports|October 6, 2015
Lysine Methyltransferase SETD7 (SET7/9) Regulates ROS Signaling through mitochondria and NFE2L2/ARE pathwayShuying He, Dafydd R Owen, Scott A Jelinsky, et al.
ACS Chemical Biology|March 22, 2021
Structure and Inhibitor Binding Characterization of Oncogenic MLLT1 MutantsXiaomin Ni, Allyn T Londregan, Dafydd R Owen, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2009
Oxygenated analogues of UK-396082 as inhibitors of activated thrombin activatable fibrinolysis inhibitorDafydd R Owen, David J Bull, Mark E Bunnage, et al.
RSC Medicinal Chemistry|January 13, 2022
Investigating 3,3-diaryloxetanes as potential bioisosteres through matched molecular pair analysisMaryne A J Dubois, Rosemary A Croft, Yujie Ding, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2009
Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysisThomas Ryckmans, Martin P Edwards, Val A Horne, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2011
Optimisation of a novel series of selective CNS penetrant CB(2) agonistsChristine Watson, Dafydd R Owen, Denise Harding, et al.
Pageof 5